Company NuVasive, Inc.
Equities
NUVA
US6707041058
Medical Equipment, Supplies & Distribution
Business Summary
Number of employees: 3,000
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 23-08-31 |
Ryan Donahoe
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Aviva McPherron
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kyle Malone
CTO | Chief Tech/Sci/R&D Officer | - | 10-03-31 |
Investor Relations Contact | - | 21-05-09 | |
Kelly Huller
SEC | Corporate Secretary | 52 | 23-08-31 |
Sean Freeman
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,324,167 | 52,305,853 ( 88.17 %) | 6,875,000 ( 11.59 %) | 88.17 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
NuVasive Netherlands BV
|
Sector
1st Jan change | Capi. | |
---|---|---|
-4.77% | 179B | |
+4.10% | 113B | |
-3.85% | 67.88B | |
+5.19% | 52.03B | |
+5.54% | 43.3B | |
+6.07% | 41.79B | |
+23.81% | 32.49B | |
+15.97% | 25.65B | |
-5.06% | 24.55B |